# Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI

> **NCT06009874** · NA · RECRUITING · sponsor: **Mohammad Hussien Tantawy Soliman** · enrollment: 80 (estimated)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Dapagliflozin 10mg Tab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06009874
- **Lead sponsor:** Mohammad Hussien Tantawy Soliman
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06009874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06009874, "Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06009874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*